10/7/2019 | DD | Former Aceto posts $258,468 August operating loss; sales still zero
|
9/20/2019 | DD | Aceto gets extension of exclusive plan-filing period through Oct. 18
|
9/19/2019 | DD | Aceto second modified plan of liquidation confirmed by court by court
|
9/5/2019 | DD | Aceto granted OK of Arsynco debtor’s $1.05 million property sale
|
8/26/2019 | DD | Aceto reports $317,941 operating loss for July; net sales still zero
|
8/19/2019 | DD | Aceto eyes extension of exclusive plan-filing period through Oct. 18
|
8/15/2019 | DD | Aceto reports $4.95 million operating loss, zero net sales for June
|
8/13/2019 | DD | Aceto seeks approval of Arsynco debtor’s $1.05 million property sale
|
8/2/2019 | DD | Aceto posts $581,077 operating loss, no sales for month ended May 31
|
7/26/2019 | DD | Aceto granted approval of disclosure statement for Chapter 11 plan
|
7/18/2019 | DD | Aceto stockholder consortium objects to proposed disclosure statement
|
6/18/2019 | DD | Aceto gets extension of exclusive plan-filing period through Aug. 19
|
6/18/2019 | DD | Aceto submits Chapter 11 plan of liquidation and disclosure statement
|
5/31/2019 | DD | Aceto claims Aurobindo scheme led Rising Pharma to insolvency
|
5/24/2019 | DD | Aceto eyes extension of exclusive plan-filing period through Aug. 19
|
4/16/2019 | DD | Aceto secures bankruptcy court approval to sell chemicals business
|
4/15/2019 | CV | Market Commentary: Aqua America on tap; Electronics for Imaging up outright, down on hedge; Aceto jumps
|
4/10/2019 | DD | Aceto granted court approval to sell pharma business to Shore Suven
|
4/2/2019 | DD | Aceto cancels pharma business auction, to seek OK of Shore Suven deal
|
3/19/2019 | DD | Aceto secures court approval of bid procedures for pharma asset sale
|
3/15/2019 | DD | Aceto gets final court approval to access $60 million DIP facility
|
3/8/2019 | CV | Market Commentary: Pluralsight convertible notes in focus; Aceto jumps; AMAG contracts; NIO down again
|
3/8/2019 | DD | Aceto seeks court approval of bid procedures for pharma asset sale
|
3/8/2019 | CV | Market Commentary: Morning Commentary: Pluralsight’s new convertibles remain in focus; Aceto notes jump
|
3/8/2019 | DD | Aceto gets $15 million stalking horse bid for Rising Pharmaceuticals
|
3/1/2019 | CV | Market Commentary: Applied Optoelectronics convertibles up on debut; Nutanix drops; Tesla due date arrives
|
2/22/2019 | DD | Aceto granted interim approval to access $15 million of financing
|
2/21/2019 | DD | Aceto seeks court approval of cash collateral use, DIP financing
|
2/20/2019 | CV | Market Commentary: Fortive’s convertibles hit market, expand on debut; Intercept contracts; Aceto eyed
|
2/20/2019 | BKCVDD | Aceto files bankruptcy, inks $338 million deal for chemicals business
|
9/12/2018 | BK | Aceto gets limited waiver of default under amended credit agreement
|
5/4/2018 | CV | Market Commentary: Five9 and Teladoc hit the market; Gogo, Pandora active; Aceto’s prospects improve
|
4/24/2018 | CV | Market Commentary: Atlassian deal looks rich; JPMorgan notes on tap; Aceto tanks; Trinity Industries active
|
8/25/2017 | BKBWCV | Aceto paying down $368 million debt from Citron, Lucid purchase
|
12/21/2016 | BK | Aceto closes $225 million restated revolver, $150 million term loan
|
11/4/2016 | BK | Aceto expects to get $150 million term loan A for generic products buy
|
8/26/2016 | BWCV | Aceto: Convertibles increased balance sheet, reduced net debt
|
11/23/2015 | CV | Aceto greenshoe ups convertibles due 2020 to $143.75 million
|
11/12/2015 | CV | Market Commentary: SunEdison near lows; Nvidia flat; International Consolidated Airlines sells €1 billion
|
11/11/2015 | CV | Market Commentary: Aceto flat to lower outright, adds on swap; SunEdison extends slide; Horizon Pharma drops
|
11/11/2015 | CV | Market Commentary: Morning Commentary: New Aceto slips outright with lower shares; SunEdison falling like a knife
|
11/11/2015 | CV | New Issue: Aceto prices $125 million five-year convertibles to yield 2%, up 30%
|
11/10/2015 | PP | Market Commentary: SunEdison, Aegerion contract sharply on hedge; new Aceto looks cheap, up in gray market
|
11/10/2015 | CV | Market Commentary: SunEdison, Aegerion contract sharply on hedge; new Aceto looks cheap, up in gray market
|
11/10/2015 | CV | Market Commentary: Morning Commentary: Planned Aceto looks cheap, shares fall; SunEdison 2.75% notes drop to 58
|
11/9/2015 | CV | Market Commentary: Iconix, Horizon Pharma regain ground after steep losses; Priceline 1% expands on swap
|
11/9/2015 | CV | Aceto to price $125 million five-year convertibles to yield 1.75%-2.25%, up 27.5%-32.5%
|
10/28/2015 | BK | Aceto restates credit agreement to lift revolving credit commitments
|
6/25/2015 | BK | Aceto increases revolving commitments to $75 million
|
3/31/2014 | BK | Aceto plans $130 million facility led by JPMorgan and Wells Fargo
|
12/20/2010 | BK | Aceto to get $80 million facility for Rising Pharmaceuticals purchase
|